Genmab — Oktober 2018

jkj

Godmorgen

bibob

God morgen.

transalp

Go morgen

polle1

God morgen og god dag

E_L

There will also be data for …… and ofatumumab (OMB157), https://www.nasdaq.com/article/novartis-to-present-33-scientific-abstracts-20181010-00038

E_L

this seems just on study design https://onlinelibrary.ectrims-congress.eu/ectrims/2018/ectrims-2018/228807/ludwig.kappos.ofatumumab.versus.teriflunomide.in.relapsing.multiple.sclerosis.html?f=media=3*search=ofatumumab*listing=3*browseby=8

Solsen

Sounds exciting with the first self- administered subcutaneous B-cell therapy

OHW

JKY, gør ikke nar af eller skyd budbringeren. Jeg oplyser bare, hvilke scenarier der KAN udspille sig baseret på min erfaring med marked og TA.

E_L

yes @Solsen ,
a bit surprised they already come out with that statement, the study isn't even recruiting yet? https://clinicaltrials.gov/ct2/show/NCT03560739 Or has it been in the clinic before?

Solsen

Not to my knowledge.

Helge_LarsenPI-redaktør

TA versus FA: http://www.proinvestor.com/debat/76350

gentogen

ClinicalTrials.gov

(clinicaltrials.gov)

Bulder

I think ofa will be self-administered what ever they choose prefilled syringes or autoinjectors. https://www.sciencedirect.com/topics/medicine-and-dentistry/autoinjector

E_L

yes, i expect that too, and they seem optimistic about their new injection toy in that statement. I am not sure they used it already in that study @gentogen

E_L

the injection tool i mean

AaBforever

Carnegie er ikke på banen i dag.

OHW

Det kan jeg godt forstå. TA er skummel nu. Vi har brug for godt nyt, hvis vi ikke skal se 800 niveau snart.

AaBforever

Ja vi må håbe at JvdW´s fireworks snart starter...

jkj

Næh ham Carnegie Traderen er nok blevet sat under administation for dårlig performens.